Sublingual versus vaginal misoprostol in the management of missed miscarriage

Journal of the Pakistan Medical Association

Volumn 60, Issue 2, 2010, Pages 113-116

  Shah, Nusrat ^a   Azam, Syed Iqbal ^a   Khan, Nusrat Hasan ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL; PARACETAMOL;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GESTATIONAL AGE; HUMAN; INCIDENCE; LABOR INDUCTION; MISSED ABORTION; NAUSEA; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; RISK FACTOR; SHIVERING; TASTE DISORDER; TREATMENT OUTCOME;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, MISSED; ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, SUBLINGUAL; ADULT; FEMALE; HUMANS; MISOPROSTOL; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 75649114194     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Blohm F, Friden B, Milson I. A prospective longitudinal population-based study of clinical miscarriage in an urban Swedish population. BJOG 2008; 115: 176-82.
2. Creinin MD, Huang X, Westhoff C, Barnhart K, Gilles JM, Zhang J. National Institute of Child Health and Human Development Management of Early Pregnancy Failure Trial. Factors related to successful Misoprostol treatment for early pregnancy failure. Obstet Gynecol 2006; 107: 901-7.
3. Petrou S, Trinder J, Brocklehurst P, Smith L. Economic evaluation of alternative management methods of first-trimester miscarriage based on results from the MIST trial. BJOG 2006; 113: 879-89.
4. Bagratee JS, Khullar V, Regan L, Moodley J, Kagoro H. A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Hum Reprod 2004; 19: 266-71.
5. Chia KV, Oqbo VI. Medical termination of missed abortion. J Obstet Gynaecol 2002; 22: 184-6.
6. Wood S L, Brain P H. Medical Management of Missed Abortion: a randomized clinical trial. Obstet Gynecol 2002; 99: 563-6.
7. Graziosi GC, van der Steeg JW, Reuwer PH, Drogtrop AP, Bruinse HW, Mol BW. Economic evaluation of misoprostol in the treatment of early pregnancy failure compared to curettage after an expectant management. Hum Reproduct 2005; 20: 1067-71.
8. Zieman M, Fong SK, Benowitz NL, Bankster D, Damey PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997; 90: 88-92.
9. Ngai SW, Tang OS, Chan YM, Ho PC. Vaginal misoprostol alone for medical abortion up to 9 weeks of gestation: efficacy and acceptability. Hum Reprod 2000; 15: 1159-62.
10. Singh K, Fong YF, Prasad RN, Dong F. Does an acidic medium enhance the efficacy of vaginal misoprostol for pre-abortion cervical priming? Hum Reprod 1999; 14: 1635-7.
11. Ho PC, Ngai SW, Liu KL, Wong GCY, Lee SW. Vaginal misoprostol compared with oral misoprostol in termination of second trimester pregnancy. Obstet Gynecol 1997; 90: 735-8.
12. Tang OS, Schweer H, Seyberth HW, Lee SW, Ho PC. Pharmacokinetics of different routes of administration of misoprostol. Hum Reproduct 2002; 17: 332-6.
13. Khan FM, Amin A, Ahmad FL, Naeem NK. Medical Termination of First Trimester Miscarriages. Annals 2007; 13.
14. Tang OS, Lau WN, Ng EH, Lee SW, Ho PC. A prospective randomized study to compare the use of repeated doses of vaginal with sublingual misoprostol in the management of first trimester silent miscarriages. Hum Reproduct 2003; 18: 176-81.
15. Sharma D, Singhal SR, Rani XX. Sublingual misoprostol in management of missed abortion in India. Trop Doct 2007; 37: 39 40.
16. Ngai SW, Chan YM, Tang OS, Ho PC. Vaginal misoprostol as medical treatment for first trimester spontaneous abortion. Hum Reprod 2001; 16: 1493-6.
17. Tang OS, Lau WN, Chan CC, Ho PC. A prospective randomized comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy. BJOG 2004; 111: 1001-5.
18. Neilson JP, Hickey M, Vazquez J. Medical treatment for early fetal death (less than 24 weeks). Cochrane Database Syst Rev 2006; 3: CD002253.
19. Hamoda H, Ashok PW, Flett GMM, Templeton A. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation. Hum Reprod 2005; 20:2348-54.
20. Hamoda H, Ashok PW, Pow J, Flett GM, Templeton A. A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days gestation. Contraception 2003; 68: 335-8.
21. Hamoda H, Ashok PW, Flett GMM, Templeton A. A randomized controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation. BJOG 2005; 112: 1102-8.